Financial Report

Income statement of PolyPeptide Group AG

1 January - 31 December 2022 (2021: 7 April - 31 December)

kCHF

Note

2022

2021

 

 

 

 

Financial income

7

2,212

499

Service income

 

7,748

4,181

Total income

 

9,960

4,680

 

 

 

 

Personnel expenses

 

-4,512

-3,675

Other operating expenses

 

-2,372

-7,821

Interest expenses third parties

 

-162

-441

Other financial expenses

8

-6,074

-2,225

Depreciation on tangible assets

 

-71

Impairment losses on investments

9

-1,160,400

Operating result before taxes (EBT)

 

-1,163,631

-9,482

 

 

 

 

Loss before taxes

 

-1,163,631

-9,482

 

 

 

 

Taxes

 

0

-122

Net loss for the year/period

 

-1,163,631

-9,604

This website uses cookies to ensure you get the best experience on our website.Privacy statement